Insmed (INSM) Names Former AstraZeneca CEO Brennan as Director
Tweet Send to a Friend
Insmed (NASDAQ: INSM) announced the appointment of David R. Brennan to its Board of Directors. Mr. Brennan has more than ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE